In this week’s video, Dr. Brian G.M. Durie discusses various trials that were presented at ASH and the triple therapy options that are available for myeloma patients of all ages.
BOTTOM LINE:
Triple therapies are wonderful options for healthy patients over the age of 65 and can produce excellent results.
Please note that Ask Dr. Durie is designed to address myeloma questions of the broadest possible audience interest. If you have a question of a personal nature, please contact our InfoLine Coordinators at 800.452.2873 or [email protected] (Please do not send email attachments or lab reports.).
Professor of Medicine, Hematologist/Oncologist, and Honoree MD at the University of Brussels, Dr. Brian G.M. Durie is a co-founder of the IMF.
